Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > No follow through

<< Previous

Bullboard Posts

Next >>

Comment by MedStocks2on Jan 11, 2021 4:55pm

318 Views

Post# 32272073

RE:RE:No follow through

lol. Wrong chart. In any case, it seems that SGTX value is 10x Sernova without much basis for it. Just tired of waiting for news I guess. If they are cashed up now with warrants, they need to get some preclinical data out on the immune system tech.

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management